116 related articles for article (PubMed ID: 35430354)
1. Risk perception and disease knowledge in attendees of a community-based lung cancer screening programme.
Lebrett MB; Crosbie EJ; Yorke J; Hewitt K; Rowlands A; Badrick E; Gareth Evans D; Balata H; Booton R; Crosbie PAJ
Lung Cancer; 2022 Jun; 168():1-9. PubMed ID: 35430354
[TBL] [Abstract][Full Text] [Related]
2. Analysis of lung cancer risk model (PLCO
Lebrett MB; Balata H; Evison M; Colligan D; Duerden R; Elton P; Greaves M; Howells J; Irion K; Karunaratne D; Lyons J; Mellor S; Myerscough A; Newton T; Sharman A; Smith E; Taylor B; Taylor S; Walsham A; Whittaker J; Barber PV; Tonge J; Robbins HA; Booton R; Crosbie PAJ
Thorax; 2020 Aug; 75(8):661-668. PubMed ID: 32631933
[TBL] [Abstract][Full Text] [Related]
3. Attending community-based lung cancer screening influences smoking behaviour in deprived populations.
Balata H; Traverse-Healy L; Blandin-Knight S; Armitage C; Barber P; Colligan D; Elton P; Kirwan M; Lyons J; McWilliams L; Novasio J; Sharman A; Slevin K; Taylor S; Tonge J; Waplington S; Yorke J; Evison M; Booton R; Crosbie PAJ
Lung Cancer; 2020 Jan; 139():41-46. PubMed ID: 31726252
[TBL] [Abstract][Full Text] [Related]
4. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA
Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437
[TBL] [Abstract][Full Text] [Related]
5. Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester.
Crosbie PA; Balata H; Evison M; Atack M; Bayliss-Brideaux V; Colligan D; Duerden R; Eaglesfield J; Edwards T; Elton P; Foster J; Greaves M; Hayler G; Higgins C; Howells J; Irion K; Karunaratne D; Kelly J; King Z; Manson S; Mellor S; Miller D; Myerscough A; Newton T; O'Leary M; Pearson R; Pickford J; Sawyer R; Screaton NJ; Sharman A; Simmons M; Smith E; Taylor B; Taylor S; Walsham A; Watts A; Whittaker J; Yarnell L; Threlfall A; Barber PV; Tonge J; Booton R
Thorax; 2019 Apr; 74(4):405-409. PubMed ID: 29440588
[TBL] [Abstract][Full Text] [Related]
6. Targeted lung cancer screening selects individuals at high risk of cardiovascular disease.
Balata H; Blandin Knight S; Barber P; Colligan D; Crosbie EJ; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Kirwan M; Macnab A; Mellor S; Miller C; Newton T; Novasio J; Sawyer R; Sharman A; Slevin K; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Waplington S; Whittaker J; Booton R; Crosbie PAJ
Lung Cancer; 2018 Oct; 124():148-153. PubMed ID: 30268454
[TBL] [Abstract][Full Text] [Related]
7. Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation.
Goodley P; Balata H; Alonso A; Brockelsby C; Conroy M; Cooper-Moss N; Craig C; Evison M; Hewitt K; Higgins C; Johnson W; Lyons J; Merchant Z; Rowlands A; Sharman A; Sinnott N; Sperrin M; Booton R; Crosbie PAJ
Thorax; 2023 Dec; 79(1):58-67. PubMed ID: 37586744
[TBL] [Abstract][Full Text] [Related]
8. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.
Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S
Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336
[TBL] [Abstract][Full Text] [Related]
9. Baseline Results of the West London lung cancer screening pilot study - Impact of mobile scanners and dual risk model utilisation.
Bartlett EC; Kemp SV; Ridge CA; Desai SR; Mirsadraee S; Morjaria JB; Shah PL; Popat S; Nicholson AG; Rice AJ; Jordan S; Begum S; Mani A; Derbyshire J; Morris K; Chen M; Peacock C; Addis J; Martins M; Kaye SB; Padley SPG; Devaraj A;
Lung Cancer; 2020 Oct; 148():12-19. PubMed ID: 32771715
[TBL] [Abstract][Full Text] [Related]
10. LDCT lung cancer screening in populations at different risk for lung cancer.
Teles GBDS; Macedo ACS; Chate RC; Valente VAT; Funari MBG; Szarf G
BMJ Open Respir Res; 2020 Feb; 7(1):. PubMed ID: 33371010
[TBL] [Abstract][Full Text] [Related]
11. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria.
Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE
Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436
[TBL] [Abstract][Full Text] [Related]
12. Smokers' interest in a lung cancer screening programme: a national survey in England.
Quaife SL; Vrinten C; Ruparel M; Janes SM; Beeken RJ; Waller J; McEwen A
BMC Cancer; 2018 May; 18(1):497. PubMed ID: 29716550
[TBL] [Abstract][Full Text] [Related]
13. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO
Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K
Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359
[TBL] [Abstract][Full Text] [Related]
14. When to reinvite initially ineligible populations for targeted lung cancer screening?
Goodley P; Crosbie PAJ; Sperrin M; Merchant Z; Booton R; Balata H
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754907
[TBL] [Abstract][Full Text] [Related]
15. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry.
Manners D; Hui J; Hunter M; James A; Knuiman MW; McWilliams A; Mulrennan S; Musk AW; Brims FJ
Med J Aust; 2016 Jun; 204(11):406. PubMed ID: 27318396
[TBL] [Abstract][Full Text] [Related]
16. Risk Perception Among a Lung Cancer Screening Population.
Turner J; Pond GR; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Tammemagi MC; Puksa S; Atkar-Khattra S; Tsao MS; Lam S; Goffin JR
Chest; 2021 Aug; 160(2):718-730. PubMed ID: 33667493
[TBL] [Abstract][Full Text] [Related]
17. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
[TBL] [Abstract][Full Text] [Related]
18. Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial.
Crosbie PAJ; Gabe R; Simmonds I; Hancock N; Alexandris P; Kennedy M; Rogerson S; Baldwin D; Booton R; Bradley C; Darby M; Eckert C; Franks KN; Lindop J; Janes SM; Møller H; Murray RL; Neal RD; Quaife SL; Upperton S; Shinkins B; Tharmanathan P; Callister MEJ
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 35777775
[TBL] [Abstract][Full Text] [Related]
19. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
Robbins HA; Alcala K; Swerdlow AJ; Schoemaker MJ; Wareham N; Travis RC; Crosbie PAJ; Callister M; Baldwin DR; Landy R; Johansson M
Br J Cancer; 2021 Jun; 124(12):2026-2034. PubMed ID: 33846525
[TBL] [Abstract][Full Text] [Related]
20. Attendees of Manchester's Lung Health Check pilot express a preference for community-based lung cancer screening.
Balata H; Tonge J; Barber PV; Colligan D; Elton P; Evison M; Kirwan M; Novasio J; Sharman A; Slevin K; Taylor S; Waplington S; Booton R; Crosbie PA
Thorax; 2019 Dec; 74(12):1176-1178. PubMed ID: 31481631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
